Kenvue generated $3.78 billion in Q4 2025 net sales, up 3.2% year over year, with diluted EPS of $0.17 and adjusted diluted EPS of $0.27. Gross margin remained flat at 56.5%, while operating income margin improved to 14.2%, supported by productivity initiatives and favorable price realization.

Kenvue delivered Q3 2025 results marked by a 3.5% drop in net sales and a 4.4% decline in organic sales. Despite volume challenges, the company held margins steady through cost efficiencies. Net income rose slightly, while adjusted EPS remained flat year-over-year.

Kenvue experienced a decline in net sales and organic sales in Q2 2025, primarily due to unfavorable value realization and volume decline. Despite this, the company reported a substantial increase in net income and diluted EPS compared to the prior year, largely due to the absence of significant asset impairment charges that affected the previous year's results. Gross profit margin and adjusted gross profit margin contracted, while operating income margin saw a significant improvement.

Kenvue faced a 3.9% drop in net sales in Q1 2025, primarily due to a 2.7% foreign exchange impact and a 1.2% organic sales decline. Despite these challenges, the company improved its gross profit margin to 58.0%, increased operating income, and achieved higher diluted EPS year-over-year. The adjusted EPS and margins, however, declined slightly. Kenvue updated its FY2025 outlook to reflect tariff and currency pressures.

Kenvue reported a slight decrease in net sales for Q4 2024, but organic sales grew. The company delivered on its 2024 profit commitments despite headwinds and is focused on accelerating growth and delivering long-term value creation.

Kenvue reported a slight decrease in net sales of 0.4% to $3.9 billion, but organic growth increased by 0.9%. The company's diluted EPS was $0.20, and adjusted diluted EPS was $0.28. They are reaffirming their outlook for Adjusted diluted earnings per share in the range of $1.10-$1.20.

Kenvue reported a slight decrease in net sales, but organic growth showed a positive trend. The company is focused on accelerating investment in brands for future growth, with reaffirmed financial targets for 2024.

Kenvue reported a 1.1% increase in net sales to $3.9 billion, with organic growth of 1.9%. Diluted earnings per share were $0.15, and adjusted diluted earnings per share were $0.28. The company reaffirmed its fiscal year 2024 outlook.

Kenvue reported a decrease in net sales by (2.7)% to $3.7 billion with organic growth declining by (2.4)% in Q4 2023. Diluted earnings per share stood at $0.17, while adjusted diluted earnings per share was $0.31.

Kenvue reported a 3.3% increase in net sales to $3.9 billion and a 3.6% increase in organic growth for the third quarter of 2023. The company's performance was driven by strength in the Self Care segment, while facing challenges from portfolio rationalization and market softness in China. The company has tightened its full year outlook due to foreign exchange headwinds and a slow start to the cough, cold, and flu season.

Kenvue's second quarter results showed a 5.4% increase in net sales to $4.0 billion, with organic growth of 7.7%. The company reported EPS of $0.23 and adjusted EPS of $0.32. Kenvue also initiated a quarterly cash dividend.